Australia markets closed

Disc Medicine, Inc. (IRON)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
30.36-0.41 (-1.33%)
At close: 04:00PM EDT
29.77 -0.59 (-1.94%)
After hours: 04:52PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 750.55M
Enterprise value 409.96M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.22
Enterprise value/revenue N/A
Enterprise value/EBITDA -7.19

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-5.12%
S&P500 52-week change 326.27%
52-week high 377.60
52-week low 325.60
50-day moving average 343.79
200-day moving average 352.23

Share statistics

Avg vol (3-month) 3493.58k
Avg vol (10-day) 3309.04k
Shares outstanding 524.72M
Implied shares outstanding 624.72M
Float 813.68M
% held by insiders 113.35%
% held by institutions 190.85%
Shares short (30 Apr 2024) 41.67M
Short ratio (30 Apr 2024) 42.14
Short % of float (30 Apr 2024) 47.91%
Short % of shares outstanding (30 Apr 2024) 46.76%
Shares short (prior month 28 Mar 2024) 41.86M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 330 Dec 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-20.37%
Return on equity (ttm)-28.23%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -97.36M
Net income avi to common (ttm)-80.6M
Diluted EPS (ttm)-3.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)342.62M
Total cash per share (mrq)13.86
Total debt (mrq)2.03M
Total debt/equity (mrq)0.60%
Current ratio (mrq)23.70
Book value per share (mrq)13.69

Cash flow statement

Operating cash flow (ttm)-71.59M
Levered free cash flow (ttm)-51.57M